TORC Key Statistics, Chart & Performance
The current stock price of TORC is 2.28 null. In the past month the price increased by 1.33%. In the past year, price decreased by -76.45%.
About TORC
Company Profile
resTORbio, Inc. is a clinical-stage biopharmaceutical company. It focused on the development and commercialization of therapeutics for the treatment of aging-related diseases. The company's program consists of rapamycin complex 1 pathway to treat aging-related diseases and conditions. Its lead product candidate, RTB101 is an orally administered, small molecule, potent TORC1 inhibitor which is in clinical stage. resTORbio, Inc. is based in BOSTON, United States.
Company Info
Restorbio Inc
500 BOYLSTON STREET 13TH FLOOR
BOSTON MA 02116
CEO: Chen Schor
Phone: 857-315-5528
Restorbio Inc / TORC FAQ
What does Restorbio Inc do?
resTORbio, Inc. is a clinical-stage biopharmaceutical company. It focused on the development and commercialization of therapeutics for the treatment of aging-related diseases. The company's program consists of rapamycin complex 1 pathway to treat aging-related diseases and conditions. Its lead product candidate, RTB101 is an orally administered, small molecule, potent TORC1 inhibitor which is in clinical stage. resTORbio, Inc. is based in BOSTON, United States.
What is the current price of TORC stock?
The current stock price of TORC is 2.28 null. The price decreased by -3.8% in the last trading session.
Does TORC stock pay dividends?
TORC does not pay a dividend.
What is the ChartMill rating of Restorbio Inc stock?
TORC has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Would investing in Restorbio Inc be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on TORC.
TORC Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to TORC. When comparing the yearly performance of all stocks, TORC is a bad performer in the overall market: 90.99% of all stocks are doing better.
TORC Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to TORC. TORC has a great financial health rating, but its profitability evaluates not so good.
TORC Financial Highlights
Over the last trailing twelve months TORC reported a non-GAAP Earnings per Share(EPS) of -12.670000000000002. The EPS decreased by -29.29% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -88.75% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |